News
Progenics Should Outperform The Market In The Short Term - Seeking Alpha
< strong > By < a href='http://binaryleverage.com/' > Niall Corrigan < /a > : < /strong > < p > < strong > Overview < /strong > < br/ > By a strange coincidence, I am currently long both Progenics Pharmaceuticals Inc. ( < a href='http://seekingalpha.com/symbol/pgnx' title='Progenics Pharmaceuticals
New Release! Advanced Back Pain Therapy (NST) Training Course via Online DVD | PRLog
New Release! Advanced Back Pain Therapy (NST) Training Course via Online DVD. Neurostructural Integration Technique (NST) is a back pain therapy that belongs in the toolbox of any serious chiropractor, osteopath, physiotherapist, massage therapist. The NST Advanced DVD Training System launches in
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. By - Prof Augusto Caraceni MD, Prof Geoffrey Hanks DSc (Med), Prof Stein Kaasa MD, Prof Micha...
Federal Court Dismisses Whistleblower Lawsuit
SAN DIEGO, Feb. 3, 2012 /PRNewswire/ -- On January 30, 2012, US District Court Judge Joseph L. Tauro ordered the complete dismissal of a whistleblower
Midwives and doctors differ in their pain relief choice | 6minutes
Obstetricians prefer pharmacological pain relief during childbirth while midwives prefer a shower and a heatpack, new Australian research suggests.
Leading Cause of Medical Evacuation Out of War Zones: It's Not Combat Injury - 01/22/2010
The most common reasons for medical evacuation of military personnel from war zones in Iraq and Afghanistan in recent years have been fractures, tendonitis and other musculoskeletal and connective tissue disorders, not combat injuries, according to results of a Johns Hopkins study published January
Phosphagenics, TPM, diclofenac, topical non-steroidal pain formulation, Themis Medicare, Indian
Phosphagenics has licensed TPM/diclofenac, its topical non-steroidal pain formulation, to Themis Medicare of Mumbai for the Indian market. This represents Phosphagenics’ first commercial deal in India and its first licensing agreement of its diclofenac product. Under the terms of the agreement,
Pain Therapeutics - Drugs, Markets and Companies | SYS-CON MEDIA
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.
amednews: Changes in medical device information pose lawsuit risks for doctors :: Dec. 19, 2011 ...
In the Courts - A column analyzing the impact of recent court decisions on physicians
Global Spinal Surgery Market to Reach US$9.3 Billion by 2017, According to New Report by Global
GIA announces the release of a comprehensive global report on Spinal Surgery market. The global market for Spinal Surgery is projected to reach US$9.3 billion by the year 2017, driven by the rising incidences of chronic back pain, an aging population, and increased awareness levels. In addition,
Refine by Topic:
Refine by Content Type:
Refine by Source:
- www.prlog.org (1,478)
- www.thelancet.com (846)
- www.webmd.com (363)
- arthritis.webmd.com (267)
- www.em-consulte.com (241)
- www.aerzteblatt.de (241)
- download.thelancet.com (231)
- www.australiandoctor.com.au (216)
- www.prweb.com (176)
- www.medpagetoday.com (161)
- www.biospace.com (139)
- women.webmd.com (83)
